• Activity INFORMATION

  Overview

  The content will review available pharmacotherapy for obesity. There have been multiple updates in 2022 and 2023 including a pending approval for a new medication and several in the pipeline. There have also been several clinical implications for the GLP1s including drug shortages, compounding questions, mortality benefit findings, and coverage questions.
  

  Handouts

  • Slide Document :   24043H01_2pp.pdf Download

  • Slide Document :   24043H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recall clinical pearls for GLP1 utilized for weight management

  Identify current treatment options for weight loss

  Recognize novel therapies being studied for weight management

  Pharmacy Technician

  Recognize novel therapies being studied for weight management

  Identify current treatment options for weight loss

  Recall clinical pearls for GLP1 utilized for weight management

  Nurse

  Recognize novel therapies being studied for weight management

  Recall clinical pearls for GLP1 utilized for weight management

  Identify current treatment options for weight loss

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1184478

  Universal Activity Number

  Pharmacist 0798-0000-24-043-H01-P
  Pharmacy Technician 0798-0000-24-043-H01-T
  Nurse 0798-0000-24-043-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Megan  Adelman, PharmD, BCPS, BCGP, CDE Family Medicine Pharmacy Specialist, Cleveland Clinic Akron General

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).